As shown in Figure 3D, NAC pre-treatment blocked TQ-induced down-regulation of NFκB targets; IκBα, Bcl-2 and Survivin confirming the mode of action of TQ being ROS release in ABC cells. This evidence concerns the gene BIRC5 and aneurysmal bone cyst.